Precision Optics NASDAQ: POCI reported a 22% increase in fiscal first-quarter revenue and a narrower loss, but executives said a slowdown in satellite component shipments will make the current quarter the weakest of the year.
Revenue for the quarter ended September 30, 2026, rose to $8.2 million from $6.7 million a year earlier, though it fell from a record $8.8 million in the preceding quarter. Chief Executive Officer Joe Forkey said manufacturing exceeded internal expectations, even as shipments to an established satellite customer declined.
The company reiterated its fiscal 2027 forecast for revenue of $30 million to $33 million and an adjusted EBITDA loss of $1.2 million to $1.7 million. Management expects the second-quarter adjusted EBITDA loss to exceed the approximately $200,000 loss recorded in the first quarter.
Satellite Orders Drive Near-Term Outlook
Revenue from the established satellite customer’s optical communications sub-assembly program fell 39% sequentially to $2.3 million in the first quarter. Forkey expects it to decline further to $1.2 million in the second quarter before recovering to approximately $2 million in each of the following two quarters.
The customer placed a follow-on order sooner than Precision Optics had expected and shared downstream build and launch plans, Forkey said. The company has also begun early-stage discussions about manufacturing additional optical sub-assemblies for the customer, though he cautioned that those talks are preliminary.
A second satellite communications customer issued a follow-on engineering order in late September. Forkey said Precision Optics completed a first-round prototype design on schedule and within budget, and that the customer intends for the company to manufacture the product once development is complete.
Management gave differing indications of the production timetable. Forkey said the customer anticipated production in the fourth quarter of calendar 2028, while also referring to production beginning about a year from now and to growth from the program in the first half of fiscal 2028.
Medical Programs Move Toward Production
Precision Optics generated approximately $1.8 million in quarterly production revenue from its single-use cystoscope program and $581,000 from a single-use ophthalmic program. Forkey said the ophthalmic line is still ramping and its quarterly revenue could double over the next couple of quarters.
For the cystoscope, future revenue will depend on market adoption and the balance between Precision Optics’ manufacturing and royalties from units produced by its customer, Forkey said. He expects a similar bottom-line contribution under either arrangement.
The company began production of a ureteroscope optical sub-assembly during the first quarter and restarted production of an endoscope used in robotic surgery after roughly two years of design and process updates. Two more programs—a micro endoscope for arthroscopic use and an aerospace borescope—are expected to move into production over the next six to nine months.
Forkey said the four programs are expected to reach a combined annual revenue run rate of $1.5 million to $2 million by the end of fiscal 2027 and eventually contribute approximately $5 million to $6 million annually. He added that the robotic surgery endoscope could reach $2 million to $3 million annually over the longer term.
Margins Improve From a Year Earlier
Gross margin rose to 22.5% from 14.2% a year earlier, helped by higher production volumes and manufacturing efficiencies, Chief Financial Officer Wayne Coll said. Margin declined from 25.3% in the preceding quarter, which included a tariff-related benefit of roughly 3 percentage points.
Net loss narrowed to approximately $475,000, or 4 cents per share, from $1.6 million, or 21 cents per share, a year earlier. The adjusted EBITDA loss improved from approximately $1.2 million. Adjusted EBITDA is a non-GAAP measure.
Coll said reduced satellite demand will pressure margins in the second quarter, with improvement expected as production recovers later in the year. Precision Optics ended September with approximately $9 million in cash and cash equivalents and $1.1 million in total bank debt, including current maturities.
New Markets Under Review
Forkey said Precision Optics is evaluating opportunities beyond its established medical device and satellite communications markets, including optical applications related to computing and artificial intelligence. The company has begun discussions with a potential customer seeking a smaller optical communications terminal for CubeSats.
However, Forkey said Precision Optics is not currently working with customers on optical communications terminals for aircraft or ground vehicles, and has not been in direct contact with companies working on AI data centers.
About Precision Optics (NASDAQ:POCI)
Precision Optics Corporation, Inc. designs and manufactures optical systems and components for medical, defense, aerospace and industrial applications. Its work spans product development, prototyping, engineering and production for customers seeking specialized imaging solutions. The company's products include rigid and flexible endoscopes, three-dimensional endoscopic imaging systems, micro-optics and other precision optical assemblies. Its offerings support medical-device makers and other organizations that need compact, high-performance imaging equipment.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Precision Optics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Precision Optics wasn't on the list.
While Precision Optics currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.